Drug firm Mankind Pharma on Thursday said it has received licence from the Defence Research and Development Organisation (DRDO) to manufacture and market oral 2-deoxy-D-glucose (2-DG), used for the treatment of COVID-19. 2-DG was developed by the Defence Research and Development Establishment (DRDE), Gwalior. The clinical trials were conducted by …
Read More »Mankind Pharma inks distribution pact with BDR Pharmaceuticals for COVID drug
Mankind Pharma on Thursday said it has inked a pact with BDR Pharmaceuticals for distributing Baricitinib, a drug that is used in COVID treatment. The product, which would be sold under the BARIKIND trademark, has received restricted emergency use approval for use in combination with remdesivis in the treatment of …
Read More »